(Q30587781)

English

Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 June 2017

Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881. (English)

1 reference

Europe PubMed Central

25 June 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kobrinsky NL

1

1 reference

Europe PubMed Central

25 June 2017

Packer RJ

2

1 reference

Europe PubMed Central

25 June 2017

Boyett JM

3

1 reference

Europe PubMed Central

25 June 2017

Stanley P

4

1 reference

Europe PubMed Central

25 June 2017

Shiminski-Maher T

5

1 reference

Europe PubMed Central

25 June 2017

Allen JC

6

1 reference

Europe PubMed Central

25 June 2017

Garvin JH

7

1 reference

Europe PubMed Central

25 June 2017

Stewart DJ

8

1 reference

Europe PubMed Central

25 June 2017

Finlay JL

9

1 reference

Europe PubMed Central

25 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1999

1 reference

Europe PubMed Central

25 June 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

25 June 2017

45

1 reference

Europe PubMed Central

25 June 2017

1

1 reference

Europe PubMed Central

25 June 2017

47-54

1 reference

Europe PubMed Central

25 June 2017

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide sensitivity of radioresistant human glioma cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose etoposide in the treatment of relapsed primary brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of recurrent medulloblastoma to low-dose oral etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide in the treatment of pediatric malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose etoposide for refractory malignancies: a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic oral VP-16 for recurrent medulloblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penetration of teniposide (VM-26) into human intracerebral tumors. Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin B or oral glycerol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of etoposide single-agent activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased deoxycytidine kinase activity by etoposide in L1210 murine leukemic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide for the treatment of paediatric tumours: what is the best way to give it?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of current clinical experience with prolonged (oral) etoposide in cancer treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide: twenty years later.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent cerebellar gliomas: salvage therapy with oral etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral therapy for small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10728909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006333811437

1 reference

Europe PubMed Central

25 June 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30587781&oldid=1984500174"